美国的医药品物流市场:类型·次序·零组件·用途·业务·各地区的机会及预测 (2018-2032年)

美国医药物流市场规模预计将从2024年的246.9亿美元成长到2032年的454亿美元，复合年增长率为7.91%。

这一增长主要得益于生物製药的兴起、冷链监控技术的快速发展以及临床试验的日益分散化。该市场正成为全球最复杂、任务最关键的物流领域之一。医药物流的市场结构以高精度、合规性和严格的温度控制为驱动力，它不仅运输产品，还保障公众健康。

本报告研究了美国医药物流市场，提供了市场定义和概述、市场规模趋势和预测、细分市场的详细分析、案例研究、影响市场成长的因素分析、竞争格局以及主要公司的概况。

目录

第1章 计划的范围和定义

第2章 调查手法

第3章 美国的关税的影响

第4章 摘要整理

第5章 客户的迴响

• 法规遵守
• 品管和可追溯性
• 在产业的经验和评价
• 顾客服务与支援

第6章 美国的医药品物流市场展望

• 市场规模的分析·预测
• 市场占有率的分析·预测
  • 类别
    • 低温运输物流
    • 非低温运输物流
  • 按次序
    • 拣货
    • 保管
    • 搜索系统
    • 处理系统
  • 各零件
    • 保管
    • 运输
    • 监视零组件
  • 各用途
    • 化学药品
    • 生物医药品
    • 专门医药品
  • 按营运
    • 海路
    • 道路
    • 铁路
    • 航空路线
    • 保管·服务
  • 各地区
    • 东北部
    • 西南部
    • 西部
    • 东南部
    • 中西部
  • 各企业市场占有率分析(前五名公司以及其他)
• 市场地图分析

第7章 供需分析

第8章 价值链分析

第9章 波特的五力分析

第10章 大环境分析

第11章 服务价格设定模式

第12章 市场动态

• 推动市场要素
• 市场课题

第13章 市场趋势·发展

第14章 政策和法规情形

第15章 案例研究

第16章 竞争情形

• 前五名公司的竞争矩阵
• 前五名公司的SWOT分析
• 前十大企业的形势
  • United Parcel Service, Inc.
  • FedEx Corporation
  • DHL Supply Chain & Global Forwarding (Deutsche Post AG)
  • Lineage Logistics Holdings, LLC
  • Americold Realty Trust, Inc.
  • Expeditors International of Washington, Inc.
  • SEKO Logistics, Inc.
  • Owens & Minor, Inc.
  • Penske Truck Leasing Co., L.P. (Penske Logistics)
  • XPO, Inc. (formerly XPO Logistics, Inc.)

第17章 策略性建议

第18章 关于调查公司·免责声明

United States pharmaceutical logistics market is projected to witness a CAGR of 7.91% during the forecast period 2025-2032, growing from USD 24.69 billion in 2024 to USD 45.40 billion in 2032F, owing to biologics taking center stage, rapid innovations in cold chain monitoring, and increasingly distributed clinical trial activity. This market has quietly become one of the most complex and mission-critical logistics sectors globally. With a market built on precision, compliance, and temperature integrity, pharmaceutical logistics in the United States not only moves goods but also safeguards public health.

For instance, in April 2025, DHL Group announced a USD 2.3 billion (EUR 2 billion) strategic investment over the next five years to boost its logistics capabilities in the life sciences and healthcare sector. Supporting its "Strategy 2030," the investment will enhance DHL's infrastructure, technology, and cold chain solutions globally, with 50% allocated to the Americas and the remainder to other regions.

Cold Chain Infrastructure Expansion to Meet Biologic and Vaccine Demands Leads to Market Growth

Biopharmaceuticals and vaccine logistics have emerged as key growth areas in the United States pharmaceutical logistics, driven by heightened demand for temperature-sensitive therapies and the need for ultra-cold storage. For instance, in April 2024, Americold Realty Trust broke ground on a new 335,000-square-foot temperature-controlled facility in Missouri, in partnership with CPKC Rail. A few of the facility's features include deep-frozen zones, real-time monitoring, and rail access right outside the door. All designed to keep cross-border pharma moving, fast, safe, and at the right temperature. Every detail screams pharma-grade-nothing left to chance. These investments reflect a broader trend as cold storage is now central to logistics strategy, not just an operational add-on.

Increasing Regulatory Compliance and Certification for Pharma Handling

United States logistics firms are actively investing in globally recognized pharma certifications to win high-value contracts and ensure compliance with stringent domestic and international handling protocols. For instance, in May 2025, FedEx became the first global integrator to earn IATA CEIV Pharma corporate certification for its entire ground-handling network. This move reinforced its leadership in temperature-sensitive and compliant logistics. This milestone underscores how compliance has become a key competitive advantage. With increasing FDA scrutiny and pharmaceutical clients demanding zero-defect delivery, certified partners are becoming the default.

Specialized Pharma Driving Service Differentiation Across Logistics Chains

Specialized pharmaceuticals, from gene therapies and personalized oncology drugs to treatments for rare diseases, are reshaping the United States logistics landscape. These products demand ultra-narrow handling tolerances, GPS-enabled real-time monitoring, and delivery windows that leave no margin for error. In April 2025, United Parcel Service, Inc. expanded its specialty temperature-controlled facilities and specialized in cold chain transportation network through the acquisition of Andlauer Healthcare Group Inc. for USD 1.6 billion. This acquisition will enhance our end-to-end capabilities and services to healthcare customers requiring temperature-controlled logistics solutions in United States.

This reflects a larger trend, as therapies get more individualized, so must the logistics behind them. Custom kitting, end-to-end tracking, and validated SOPs are no longer differentiators; they are minimum requirements.

Impact of U.S. Tariffs on United States Pharmaceutical Logistics Market

Tariffs on imported APIs, medical supplies, and logistics equipment increase production and transportation expenses. Pharma companies often pass these costs to consumers, leading to rising drug prices.

Dependence on China and India for APIs forces companies to diversify suppliers or shift production to the U.S./Mexico. Temporary shortages and stockpiling occur due to trade uncertainties.

Refrigeration units, packaging materials, and tracking devices become more expensive due to tariffs. Increased demand for U.S.-based cold storage as companies hold more inventory domestically.

Switching suppliers requires FDA reapprovals, slowing down drug distribution. Companies invest in AI, blockchain, and nearshoring to optimize tariff-affected supply chains.

Key Players Landscape and Outlook

Major players dominate the United States pharmaceutical logistics market, with some being global and others homegrown. They promise cold chain warehousing, certified transport, and real-time tracking. They cater to biologics, vaccines, and clinical trials. Then you have the cold storage experts. Americold and Lineage Logistics are investing heavily, expanding, automating, and upgrading for the pharmaceutical industry. SEKO Logistics and Expeditors are tightening air-cargo links. Owens & Minor, All about medical fulfillment and hospital supplies. Personalized medicine is booming. Temperature-sensitive therapies are everywhere. Regulations are more challenging than ever. Now, it is not just about trucks and warehouses; it is about compliance, traceability, and speed.

For instance, in April 2025, Lineage, Inc. announced a significant expansion of its United States cold-storage network through a series of acquisitions, greenfield developments, and advanced automation projects. As part of this initiative, Lineage has entered a definitive agreement to acquire multiple cold storage warehouses from Tyson Foods, Inc., strengthening its longstanding partnership. Additionally, Lineage will design, build, and operate two next-generation, fully automated cold storage facilities in key United States distribution markets, with Tyson Foods serving as the anchor tenant. Lineage plans to invest approximately USD 1 billion in these acquisitions and new developments over the coming years.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Voice of Customers

• 5.1. Regulatory Compliance
• 5.2. Quality Management and Traceability
• 5.3. Industry Experience and Reputation
• 5.4. Customer Service and Support

6. United States Pharmaceutical Logistics Market Outlook, 2018-FY2032F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Type
    • 6.2.1.1. Cold Chain Logistics
    • 6.2.1.2. Non-Cold Chain Logistics
  • 6.2.2. By Procedure
    • 6.2.2.1. Picking
    • 6.2.2.2. Storage
    • 6.2.2.3. Retrieval Systems
    • 6.2.2.4. Handling Systems
  • 6.2.3. By Component
    • 6.2.3.1. Storage
    • 6.2.3.2. Transportation
    • 6.2.3.3. Monitoring Components
  • 6.2.4. By Application
    • 6.2.4.1. Chemical Pharma
    • 6.2.4.2. Biopharma
    • 6.2.4.3. Specialized Pharma
  • 6.2.5. By Operation
    • 6.2.5.1. Seaways
    • 6.2.5.2. Roadways
    • 6.2.5.3. Railways
    • 6.2.5.4. Airways
    • 6.2.5.5. Storage and Services
  • 6.2.6. By Region
    • 6.2.6.1. Northeast
    • 6.2.6.2. Southwest
    • 6.2.6.3. West
    • 6.2.6.4. Southeast
    • 6.2.6.5. Midwest
  • 6.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2024)
• 6.3. Market Map Analysis, 2024
  • 6.3.1. By Type
  • 6.3.2. By Procedure
  • 6.3.3. By Component
  • 6.3.4. By Application
  • 6.3.5. By Operation
  • 6.3.6. By Region

7. Demand Supply Analysis

8. Value Chain Analysis

9. Porter's Five Forces Analysis

10. PESTLE Analysis

11. Service Pricing Model

12. Market Dynamics

• 12.1. Market Drivers
• 12.2. Market Challenges

13. Market Trends and Developments

14. Policy and Regulatory Landscape

15. Case Studies

16. Competitive Landscape

• 16.1. Competition Matrix of Top 5 Market Leaders
• 16.2. SWOT Analysis for Top 5 Players
• 16.3. Key Players Landscape for Top 10 Market Players
  • 16.3.1. United Parcel Service, Inc.
    • 16.3.1.1. Company Details
    • 16.3.1.2. Key Management Personnel
    • 16.3.1.3. Products and Services
    • 16.3.1.4. Financials (As Reported)
    • 16.3.1.5. Key Market Focus and Geographical Presence
    • 16.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 16.3.2. FedEx Corporation
  • 16.3.3. DHL Supply Chain & Global Forwarding (Deutsche Post AG)
  • 16.3.4. Lineage Logistics Holdings, LLC
  • 16.3.5. Americold Realty Trust, Inc.
  • 16.3.6. Expeditors International of Washington, Inc.
  • 16.3.7. SEKO Logistics, Inc.
  • 16.3.8. Owens & Minor, Inc.
  • 16.3.9. Penske Truck Leasing Co., L.P. (Penske Logistics)
  • 16.3.10. XPO, Inc. (formerly XPO Logistics, Inc.)

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

17. Strategic Recommendations

18. About Us and Disclaimer

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. United States Pharmaceutical Logistics Market, By Value, In USD Billion, 2018-2032F
• Figure 2. United States Pharmaceutical Logistics Market Share (%), By Type, 2018-2032F
• Figure 3. United States Pharmaceutical Logistics Market Share (%), By Procedure, 2018-2032F
• Figure 4. United States Pharmaceutical Logistics Market Share (%), By Component, 2018-2032F
• Figure 5. United States Pharmaceutical Logistics Market Share (%), By Application, 2018-2032F
• Figure 6. United States Pharmaceutical Logistics Market Share (%), By Operation, 2018-2032F
• Figure 7. United States Pharmaceutical Logistics Market Share (%), By Region, 2018-2032F
• Figure 8. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 9. By Procedure Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 10. By Component Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 11. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 12. By Operation Map-Market Size (USD Billion) & Growth Rate (%), 2024
• Figure 13. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2024